TY - JOUR
T1 - Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature
AU - Nikiphorou, Elena
AU - Radner, Helga
AU - Chatzidionysiou, Katerina
AU - Desthieux, Carole
AU - Zabalan, Codruta
AU - van Eijk-Hustings, Y.
AU - Dixon, William G.
AU - Hyrich, Kimme L.
AU - Askling, Johan
AU - Gossec, Laure
PY - 2016/10/28
Y1 - 2016/10/28
N2 - Patient-reported outcomes (PROs) reflect the patient's perspective and are used in rheumatoid arthritis (RA) routine clinical practice. Patient global assessment (PGA) is one of the most widely used PROs in RA practice and research and is included in several composite scores such as the 28-joint Disease Activity Score (DAS28). PGA is often assessed by a single question with a 0-10 or 0-100 response. The content can vary and relates either to global health (e.g., how is your health overall) or to disease activity (e.g., how active is your arthritis). The wordings used as anchors, i.e., for the score of 0, 10, or 100 according to the scale used, and the timing (i.e., this day or this week) also vary. The different possible ways of measuring PGA translate into variations in its interpretation and reporting and may impact on measures of disease activity and consequently achievement of treat-to-target goals. Furthermore, although PGA is associated with objective measures of disease activity, it is also associated with other aspects of health, such as psychological distress or comorbidities, which leads to situations of discordance between objective RA assessments and PGA. Focusing on the role of PGA, its use and interpretation in RA, this review explores its validity and correlations with other disease measures and its overall value for research and routine clinical practice.
AB - Patient-reported outcomes (PROs) reflect the patient's perspective and are used in rheumatoid arthritis (RA) routine clinical practice. Patient global assessment (PGA) is one of the most widely used PROs in RA practice and research and is included in several composite scores such as the 28-joint Disease Activity Score (DAS28). PGA is often assessed by a single question with a 0-10 or 0-100 response. The content can vary and relates either to global health (e.g., how is your health overall) or to disease activity (e.g., how active is your arthritis). The wordings used as anchors, i.e., for the score of 0, 10, or 100 according to the scale used, and the timing (i.e., this day or this week) also vary. The different possible ways of measuring PGA translate into variations in its interpretation and reporting and may impact on measures of disease activity and consequently achievement of treat-to-target goals. Furthermore, although PGA is associated with objective measures of disease activity, it is also associated with other aspects of health, such as psychological distress or comorbidities, which leads to situations of discordance between objective RA assessments and PGA. Focusing on the role of PGA, its use and interpretation in RA, this review explores its validity and correlations with other disease measures and its overall value for research and routine clinical practice.
KW - Discordance
KW - Patient global assessment
KW - Rheumatoid arthritis
KW - REPORTED OUTCOMES
KW - ACTIVITY SCORE
KW - LIFE MEASURES
KW - REMISSION CRITERIA
KW - AMERICAN-COLLEGE
KW - CORE SET MEASURES
KW - VISUAL ANALOG SCALE
KW - IMPORTANT DIFFERENCE
KW - CLINICAL-TRIALS
KW - RHEUMATOLOGY/EUROPEAN LEAGUE
U2 - 10.1186/s13075-016-1151-6
DO - 10.1186/s13075-016-1151-6
M3 - Article
C2 - 27793211
SN - 1478-6354
VL - 18
JO - Arthritis Research & Therapy
JF - Arthritis Research & Therapy
M1 - 251
ER -